Cargando…
Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons
Bisphosphonates are the most widely prescribed drugs for the treatment of osteoporosis, and are also used in malignant bone metastases, multiple myeloma, and Paget's disease, and provide therapeutic efficacy on those diseases. However, it was reported that occurrence of osteonecrosis of the jaw...
Autores principales: | Kim, Kyoung Min, Rhee, Yumie, Kwon, Yong-Dae, Kwon, Tae-Geon, Lee, Jeong Keun, Kim, Deog-Yoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Bone and Mineral Research
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691589/ https://www.ncbi.nlm.nih.gov/pubmed/26713306 http://dx.doi.org/10.11005/jbm.2015.22.4.151 |
Ejemplares similares
-
Medication Related Osteonecrosis of the Jaw: 2021 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons
por: Kim, Jin-Woo, et al.
Publicado: (2021) -
Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
por: Kwon, Yong-Dae, et al.
Publicado: (2016) -
Calcium and Vitamin D Supplementations: 2015 Position Statement of the Korean Society for Bone and Mineral Research
por: Kim, Kyoung Min, et al.
Publicado: (2015) -
Bisphosphonate related osteonecrosis of the jaws (BRONJ) in osteoporotic males
por: Kwon, Yong-Dae, et al.
Publicado: (2016) -
Author’s reply to the letter to the editor of Journal of the Korean Association of Oral and Maxillofacial Surgeons
por: Lee, Jeong-Keun
Publicado: (2023)